0001127602-23-015029.txt : 20230509 0001127602-23-015029.hdr.sgml : 20230509 20230509170250 ACCESSION NUMBER: 0001127602-23-015029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230508 FILED AS OF DATE: 20230509 DATE AS OF CHANGE: 20230509 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Deschatelets Pascal CENTRAL INDEX KEY: 0001657720 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38276 FILM NUMBER: 23903154 MAIL ADDRESS: STREET 1: 6400 WESTWIND WAY STREET 2: SUITE A CITY: CRESTWOOD STATE: KY ZIP: 40014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001492422 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271537290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-977-5700 MAIL ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4.xml PRIMARY DOCUMENT X0407 4 2023-05-08 0001492422 Apellis Pharmaceuticals, Inc. APLS 0001657720 Deschatelets Pascal C/O APELLIS PHARMACEUTICALS, INC. 100 FIFTH AVENUE, 3RD FLOOR WALTHAM MA 02451 1 Chief Scientific Officer 1 Common Stock 2023-05-08 4 M 0 18500 2.67 A 1045813 D Common Stock 2023-05-08 4 S 0 12000 92.39 D 1033813 D Stock Option (Right to Buy) 2.67 2023-05-08 4 M 0 18500 0 D 2023-12-05 Common Stock 18500 109994 D This is a scheduled exercise and sale from a 10B5-1 trading plan. This stock option was granted on 12/5/2013 and is fully vested. /s/ David Watson, attorney-in-fact for Pascal Deschatelets 2023-05-09